Gaush Meditech Ltd. (2407) Financial Statements

1 Followers

Gaush Meditech Ltd. Financial Overview

Gaush Meditech Ltd.'s market cap is currently HK$774.93M. The company's EPS TTM is HK$0.66; its P/E ratio is 11.17; and it has a dividend yield of 3.48%. Gaush Meditech Ltd. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	¥ 1.38B	¥ 1.43B	¥ 1.41B	¥ 1.25B	¥ 1.30B
Gross Profit	¥ 633.20M	¥ 663.39M	¥ 691.60M	¥ 625.34M	¥ 609.47M
Operating Income	¥ 121.65M	¥ 197.19M	¥ 279.15M	¥ 246.22M	¥ 257.12M
EBITDA	¥ 169.71M	¥ 247.31M	¥ 374.31M	¥ 271.91M	¥ 287.20M
Net Income	¥ 96.19M	¥ 92.39M	¥ 173.52M	¥ -349.62M	¥ -190.45M
Balance Sheet
Cash & Short-Term Investments	¥ 440.94M	¥ 518.99M	¥ 833.04M	¥ 814.16M	¥ 609.00M
Total Assets	¥ 2.63B	¥ 2.57B	¥ 2.84B	¥ 2.72B	¥ 2.43B
Total Debt	¥ 507.37M	¥ 552.24M	¥ 664.36M	¥ 756.00M	¥ 2.62B
Net Debt	¥ 66.43M	¥ 130.80M	¥ 45.66M	¥ 34.48M	¥ 2.01B
Total Liabilities	¥ 921.65M	¥ 978.12M	¥ 1.15B	¥ 1.23B	¥ 3.06B
Stockholders' Equity	¥ 1.69B	¥ 1.58B	¥ 1.68B	¥ 1.47B	¥ -656.43M
Cash Flow
Free Cash Flow	¥ 110.47M	¥ 26.57M	¥ 203.44M	¥ 186.41M	¥ 136.44M
Operating Cash Flow	¥ 144.23M	¥ 107.78M	¥ 249.04M	¥ 234.42M	¥ 164.49M
Investing Cash Flow	¥ 20.82M	¥ 18.55M	¥ -167.65M	¥ -136.04M	¥ 79.83M
Financing Cash Flow	¥ -206.60M	¥ -303.09M	¥ -189.94M	¥ 3.08M	¥ 72.84M

Currency in CNY

Gaush Meditech Ltd. Earnings and Revenue History

Income Statement >

Gaush Meditech Ltd. Debt to Assets

Balance Sheet >

Gaush Meditech Ltd. Cash Flow

Cash Flow >

Gaush Meditech Ltd. Forecast EPS vs Actual EPS

Earnings >